Leveraging Clinical Trial Design and Execution to Improve CDx Development and Outcomes
Time: 28th March 2017, 12.30 – 17.00
12.30 Workshop Registration Opens
13.00 Trends in Precision Medicine & Companion Diagnostics
Steve Anderson, PhD – Covance, Inc.
13.45 Key Considerations: Changing Regulatory Framework in the EU & Globally
Seamus Kearney, BEng MSc – ARC Consulting (Ireland)
15:00 Optimizing CDx Clinical Trial Design, Recruitment / Enrollment & Execution
Suso Platero, PhD – Covance, Inc.
15:45 Multiplexing Technologies & CDx: Proteomic & Genomic Approaches
Jim White, PhD – NanoString Technologies (UK)
16:15 Panel: Challenges & Opportunities in Drug & Diagnostic Co-Development
Pharma, Dx & CRO perspectives to be presented
If you are interested in joining the pre-conference workshop hosted by Covance, please email firstname.lastname@example.org. If accepted, the workshop will be free to attend as part of your conference registration.
Dr. Steve Anderson, Chief Scientific Officer, Covance Inc
Steve Anderson, Chief Scientific Officer, Covance, Inc.
Flora Berisha, Associate Director, Companion Diagnostics, Daiichi Sankyo
Seamus Kearney, CEO & Principal Consultant, ARC Consulting
Peter Kerr, Vice President, Companion Diagnostic Development, Almac Diagnostics
Suso Platero, Executive Director, Immuno-Oncology & Precision Medicine Leader, Covance, Inc.
Jim White, Senior Manager, Field Application Scientist, Nanostring Technologies
Novotel London West
1 Shortlands, Hammersmith